Taking aspirin and Wegovy together: the practical questions answered

The interaction question: what the evidence actually shows

A question our prescribers hear most weeks is some version of: "I'm on aspirin, is that going to be a problem?" The reassuring clinical picture is that semaglutide and aspirin do not interact through the same receptor pathways or compete for the same enzymes. You can read the detailed breakdown on our semaglutide and aspirin interactions page, but the summary is this: the concern is practical rather than pharmacological.

Wegovy works partly by slowing how quickly the stomach empties, and if you're new to how the slimming drug Wegovy works in practice, our dedicated page covers the mechanism and what to expect from treatment. For most medicines that are swallowed whole and absorbed in the small intestine, this delay is modest and clinically unimportant. Aspirin, particularly in enteric-coated form, is designed to survive the stomach and dissolve later, so the effect on its absorption is unlikely to be dramatic. That said, "unlikely" is not the same as "irrelevant for you specifically", which is why disclosing every regular medicine at consultation matters.

The NHS medicines page for semaglutide advises telling your doctor or pharmacist about all medicines you take, including over-the-counter drugs like aspirin, before starting treatment. That list captures both the named interactions and the broader context of your health.

The cardiovascular angle: aspirin users and Wegovy eligibility

Many people who take aspirin daily do so for established cardiovascular disease, a history of heart attack, stroke, or a high predicted cardiovascular risk. This matters because Wegovy has a UK licence specifically for reducing the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with obesity or overweight who have established heart disease.

That means someone taking low-dose aspirin for secondary cardiovascular prevention could potentially be eligible for Wegovy on more than one clinical ground. Eligibility for weight management is based on BMI of 30 or above, or 27 or above with at least one weight-related condition, and a weight-related or cardiovascular condition is assessed by the prescriber in full. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance.

If you want to explore whether you qualify, our overview of Wegovy in the UK sets out the licensed indications clearly, and our clinical team profiles are on the clinical team page if you'd like to know who reviews these consultations.

Gastrointestinal symptoms: when aspirin and semaglutide's side-effect profiles overlap

Both aspirin and semaglutide can cause gastrointestinal symptoms. Aspirin (especially in higher doses or without food) is associated with stomach irritation, nausea and, at higher doses, GI bleeding risk. Semaglutide's most common side effects are also GI-led: nausea, vomiting, diarrhoea, constipation and reflux. These tend to be most noticeable when starting treatment or after a dose step, and for most people they settle within a couple of weeks.

Taking both together doesn't make a serious GI event dramatically more likely at low-dose aspirin levels, but it does mean you start with more potential irritants in play. Staying well hydrated, eating slowly, and not taking aspirin on a completely empty stomach are practical steps; your prescriber and the Patient Information Leaflet will give specific guidance for your situation. If you develop severe or persistent stomach pain that spreads to your back, seek urgent medical advice, the MHRA highlighted acute pancreatitis as an infrequent but serious risk with GLP-1 medicines in a January 2026 Drug Safety Update.

Other aspects of life on Wegovy (skin changes, vitamin levels, how it interacts with other conditions) are worth reading about too. Our pages on Wegovy and skin and B12 and Wegovy cover some of the questions that come up once treatment is underway.

What your prescriber needs from you at consultation

Declaring aspirin use upfront is the single most practical thing you can do. That means specifying the dose (75 mg daily is standard low-dose; 300 mg is a different conversation), how regularly you take it, and why, because the reason you're on aspirin tells the prescriber a great deal about your cardiovascular history and risk profile.

At a regulated online pharmacy like nume, your consultation is reviewed by a GPhC-registered Independent Prescriber, not processed by software. A real clinician reads your answers and your medication list before any prescription decision is made, that's the process for every new patient, and for every repeat order too. There's more on how it works on our treatment page.

If you've seen discussion online about taking aspirin with semaglutide and wondered whether it applied to you, the answer is always: tell your prescriber, let them map it onto your specific circumstances. A general "no known interaction" is useful context; it's not a substitute for clinical review. When you're ready to take that step, check your eligibility with our prescribers through a free consultation.